Fenbendazole, a benzimidazole drug commonly used as a Dewormer in animals, has garnered attention for potential use in humans. Originally developed to treat parasitic infections in livestock and pets, fenbendazole works by inhibiting the formation of microtubules in parasitic cells, effectively killing them. It is primarily effective against a range of intestinal parasites such as roundworms, hookworms, and whipworms.
While fenbendazole is FDA-approved for veterinary use, it is not officially approved for human use. However, anecdotal reports and ongoing studies have explored its potential in treating certain cancers due to its ability to interfere with cell division in abnormal cells. Early research has suggested that fenbendazole may exhibit anti-cancer properties by disrupting cancer cell microtubules, although more clinical evidence is needed to confirm its efficacy and safety.
Despite the promising studies, it is essential to approach the use of fenbendazole in humans with caution. Self-medicating without medical supervision can lead to side effects such as liver toxicity, and its interactions with other medications remain largely unexplored. Consultation with a healthcare provider is necessary for those considering its use, particularly outside of its approved veterinary applications.